ANADIGICS (ANAD) & IXYS (IXYS) Head to Head Comparison

ANADIGICS (NASDAQ: ANAD) and IXYS (NASDAQ:IXYS) are both technology companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, valuation, analyst recommendations, dividends, risk, institutional ownership and earnings.

Profitability

How to Become a New Pot Stock Millionaire

This table compares ANADIGICS and IXYS’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
ANADIGICS -49.89% -97.40% -69.35%
IXYS 3.95% 4.34% 3.04%

Analyst Ratings

This is a breakdown of current recommendations and price targets for ANADIGICS and IXYS, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
ANADIGICS 0 0 0 0 N/A
IXYS 0 0 0 0 N/A

Valuation & Earnings

This table compares ANADIGICS and IXYS’s top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
ANADIGICS N/A N/A N/A ($0.27) -3.15
IXYS $322.12 million 2.36 $21.34 million $0.71 32.46

IXYS has higher revenue and earnings than ANADIGICS. ANADIGICS is trading at a lower price-to-earnings ratio than IXYS, indicating that it is currently the more affordable of the two stocks.

Institutional and Insider Ownership

63.0% of IXYS shares are held by institutional investors. 23.6% of IXYS shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Summary

IXYS beats ANADIGICS on 8 of the 8 factors compared between the two stocks.

ANADIGICS Company Profile

ANADIGICS, Inc. is engaged in the designing and manufacturing of radio frequency (RF) semiconductor solutions for infrastructure and mobile communications and data transmission markets. The Company’s product portfolio includes line amplifiers, reverse path amplifiers, power amplifiers (PAs) and front-end integrated circuits (FEIC). The Company designs, develops, and manufactures RFIC’s primarily using GaAs compound semiconductor substrates with various process technologies, including metal semiconductor field effect transistor (MESFET), pseudomorphic high-electron-mobility transistor (pHEMT) and heterojunction bipolar transistor (HBT). The Company’s InGaP-Plus technology, combines InGaP HBT and pHEMT processes on a single substrate and integrates the PA function and the RF active switch function on the same die. Additionally, the Company offers VCSEL process technology. The Company fabricates its ICs in its six-inch diameter GaAs wafer fabrication facility.

IXYS Company Profile

IXYS Corporation (IXYS) is a multi-market integrated semiconductor company. The Company is engaged in the development, manufacture and marketing of power semiconductors, mixed-signal integrated circuits (ICs), application specific integrated circuits (ASICs), microcontrollers, systems and radio frequency (RF) power semiconductors. Its power semiconductors are sold separately and are also packaged in high power modules that consist of multiple semiconductor dies. Its power metal-oxide-silicon (MOS) transistors operate at greater switching speeds than bipolar transistors. Its ICs address the demand for analog, mixed-signal and digital interface solutions in communication and other industries and include microcontrollers, mixed-signal application-specific ICs. RF power devices switch electricity at the high rates necessary to enable the amplification or reception of radio frequencies. It manufactures and sells laser diode drivers, high voltage pulse generators and modulators.

Receive News & Ratings for ANADIGICS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ANADIGICS and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Zacks: Analysts Expect Qorvo  Will Post Quarterly Sales of $656.56 Million
Zacks: Analysts Expect Qorvo Will Post Quarterly Sales of $656.56 Million
$28.23 Million in Sales Expected for FibroGen  This Quarter
$28.23 Million in Sales Expected for FibroGen This Quarter
vTv Therapeutics  Expected to Post Quarterly Sales of $3.14 Million
vTv Therapeutics Expected to Post Quarterly Sales of $3.14 Million
Netko  Price Tops $0.19 on Top Exchanges
Netko Price Tops $0.19 on Top Exchanges
Onix  Reaches Market Capitalization of $324,379.00
Onix Reaches Market Capitalization of $324,379.00
Somewhat Favorable Press Coverage Somewhat Unlikely to Affect China Eastern Airlines  Share Price
Somewhat Favorable Press Coverage Somewhat Unlikely to Affect China Eastern Airlines Share Price


© 2006-2018 Ticker Report. Google+.